Tonghua Pharmaceutical Company
GPTKB entity
Properties (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired several smaller pharmaceutical companies
|
| gptkbp:awards |
gptkb:National_Quality_Award
|
| gptkbp:brand |
Well-recognized_brand_in_China
|
| gptkbp:CEO |
gptkb:Zhang_Jian
|
| gptkbp:clinicalTrials |
Conducts clinical research in various fields
Conducts clinical trials for new drugs Contributes_to_clinical_guidelines_in_China |
| gptkbp:communityEngagement |
Supports local health initiatives
|
| gptkbp:communityPartnerships |
Partners with hospitals for clinical trials
|
| gptkbp:corporateSocialResponsibility |
Engages in CSR activities
|
| gptkbp:customerService |
High customer satisfaction ratings
|
| gptkbp:distribution |
Global distribution network
|
| gptkbp:dividendYield |
Offers dividends to shareholders
|
| gptkbp:employees |
over 3,000
|
| gptkbp:exportMarkets |
Exports to over 30 countries
|
| gptkbp:financialPerformance |
Consistent revenue growth
Strong stock performance in recent years |
| gptkbp:financials |
Publishes annual financial reports
|
| gptkbp:founded |
1997
|
| gptkbp:hasResearchInterest |
Conducts extensive market research
|
| gptkbp:headCoach |
around 3,500
|
| gptkbp:headquarters |
gptkb:Tonghua,_Jilin,_China
|
| gptkbp:healthcare |
Participates in healthcare conferences
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tonghua Pharmaceutical Company
|
| gptkbp:industry |
Healthcare
|
| gptkbp:innovation |
Focus on innovative drug development
|
| gptkbp:investmentFocus |
Invests in biotechnology startups
Regular shareholder meetings Active investor relations program |
| gptkbp:market |
approximately $1 billion
Regularly launches new products Adapts to market trends Expanding_into_North_American_markets Growing_presence_in_European_markets Strong_presence_in_Asian_markets |
| gptkbp:marketingStrategy |
Focus on expansion and innovation
|
| gptkbp:partnerships |
Partnerships with universities for research
Collaborations with international pharmaceutical firms |
| gptkbp:patentCitation |
Holds numerous patents for drug formulations
|
| gptkbp:philanthropy |
Engages in philanthropic activities.
|
| gptkbp:productLine |
Medical devices
Prescription drugs Nutritional supplements Over-the-counter drugs |
| gptkbp:productQuality |
High standards of product quality
|
| gptkbp:products |
gptkb:Traditional_Chinese_Medicine
|
| gptkbp:regulatoryCompliance |
CFDA_approved_products
|
| gptkbp:research |
Receives funding for research projects
|
| gptkbp:researchFocus |
Herbal medicine
|
| gptkbp:researchInterest |
Multiple_research_institutes_in_China
|
| gptkbp:revenue |
over $500 million annually
|
| gptkbp:services |
Research_and_Development
|
| gptkbp:stockSymbol |
600090
|
| gptkbp:subsidiary |
gptkb:Tonghua_Dongbao_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:supplyChain |
Robust supply chain management
|
| gptkbp:sustainabilityInitiatives |
Focus on sustainable practices
|
| gptkbp:training |
Comprehensive employee training programs
|
| gptkbp:website |
www.tonghuapharma.com
|